SMN1 and proximal spinal muscular atrophy: Finally, regarding more specifically the SMA disease, ASC-EVs could also possibly be imagined as a synergic therapy in combination with SMN-dependent drugs to enhance their beneficial effects for the treatment of SMA patients.